Athletes who participate in weight-division sports such as taekwondo, boxing, judo, and wrestling regularly reduce their body weight severely prior to competition in order to gain a size advantage over the opponent while simultaneously meeting their weight-division requirements. In general, athletes have acute weight loss of 4 to 7 kg within 3 to 4 days of competition, while longer periods of more gradual weight loss of 15 to 22 kg occur over 3 to 4 weeks.1,2 Although this kind of extreme weight loss can induce metabolic dysfunction, it is repeatedly performed by athletes of weight division sports in order to acquire a more advantageous condition for play.3 Furthermore, athletes participating in matches tend to obtain excessive body weights compared with their weight division during the offseason in order to lift heavier weights during training, before rapidly losing that body weight over a short period of time prior to competition.4 This rapid weight change with high-intensity exercise training may result in the deterioration of the health and sports performance of these athletes, as it can lead to an abrupt disturbance of metabolism and increased oxidative stress, which can ultimately result in damage to the cells.5 This is concerning, as an impairment in lipid metabolism and an increase in free radical production can lead to greater risks of cardiovascular and metabolic disease in these athletes.6,7
Octacosanol, a straight-chain, high-molecular-weight, primary aliphatic alcohol minimally contained in the epicuticular wax of various plants may be able to prevent these deteriorations, however, as it has been shown to provide various metabolic and cardiovascular health benefits.8 For instance, octacosanol supplementation was shown to prevent an increase in adipose accumulation, serum triglyceride (TG) concentration, and glycogen accumulation, while increasing serum fatty acid content and fatty acid oxidation in experimental models fed a high-fat diet.9–11 In humans, octacosanol has been shown to improve cardiovascular function and walking capacity in patients with peripheral artery disease12; serum low-density lipoprotein (LDL) and high-density lipoprotein (HDL) concentrations in healthy adults;13 and LDL, HDL, total cholesterol, and TG levels in patients with type 2 hypercholesterolemia.14 However, the potential beneficial effects of octacosanol intake for improving cholesterol and oxidative stress that occur from sports that require excessive weight change and high-intensity exercise have not been examined. Therefore, the purpose of this study was to examine the effects of octacosanol supplementation during rapid weight loss through caloric restriction with high-intensity exercise training on lipid profiles and markers of oxidative stress in taekwondo players.
Materials and Methods
Subjects
All procedures reported in this study were conducted and performed according to the protocols approved by Kosin University’s institutional review board (KSU IRB 2017-63-HR) and carried out in accordance with the Declaration of Helsinki. This study was also registered with clinicaltrials.gov (NTC03557476). A total of 26 elite male taekwondo athletes (mean age = 18 [1] y) with at least 3 years of experience in national taekwondo competitions were recruited from Kosin University. Subject characteristics can be seen in Table 1. All participants were healthy and free from cardiovascular, metabolic, and renal diseases, and all participants received complete information about the study design and provided written informed consent. Participants were asked to abstain from caffeinated drinks, alcohol, and antioxidant supplements during the whole period of the study. All participants had no history of chronic use of antioxidants or nonsteroidal anti-inflammatory drugs.
Physical Characteristics of the Study Participants
%Fat | Body weight, kg | ||||||
---|---|---|---|---|---|---|---|
Group | Age, y | Height, cm | Career, mo | Pre | Post | Pre | Post |
OCT (n = 13) | 18 (1) | 174.7 (1.4) | 66 (10) | 8 (2) | 5 (2)* | 66.9 (6.7) | 62.5 (6.9)* |
CON (n = 13) | 18 (1) | 173.9 (6.3) | 69 (10) | 8 (2) | 5 (2)* | 66.7 (5.7) | 62.3 (6.1)* |
Abbreviations: CON, 5% weight loss with placebo intake; OCT, 5% weight loss with octacosanol intake. Note: Values are mean (SD).
*P < .05, different from pre.
Study Design
We used a double-blinded, parallel experimental design. Allocation was stratified for years of training (>3 [n = 13 in OCT group and n = 13 in CON group]), and the sequence was generated by a computer-based number. All participants were randomly divided in a 1:1 fashion into 2 groups: (1) a 5% weight loss with octacosanol intake group (OCT; n = 13) and (2) a 5% weight loss with placebo group (CON; n = 13) (Figure 1). A power analysis calculation (G*Power 3.1; Universität Kiel, Kiel, Germany) determined a minimum sample size of 26 would allow the observation of a difference of 3% to 5% between the groups (OCT vs CON) on the primary study outcome variable of body weight with a power of 80%.
Exercise Protocols
Participants performed 2 hours of a taekwondo training program at the same time of day over 6 days in a training camp. The intensity of each training sessions was 70% to 90% of predicted maximum heart rate. Subjects completed a 10-minute dynamic stretching warm-up before training began. Approximately 1 hour of the taekwondo training program was devoted to technique training and sparring, while the other hour was spent on physical training. The technique training component of the session included basic techniques, simulated fighting techniques, and simulated matches. The physical training component consisted of a circuit training program of interval sprints between various resistance training activities. The participants completed a 10-minute cooldown of static stretching at the end of the training session. The training program can be seen in Table 2. Participants wore body protectors during the entirety of the training session, and no injuries were reported. Subjects were allowed to drink water ad libitum during the training sessions.
Taekwondo Training Program
Duration, min | Exercises | Intensity | Frequency, d/wk | |||
---|---|---|---|---|---|---|
10 | Dynamic stretching | — | 6 | |||
Kicks | Punches | Step sparring | Forms | |||
60 | Front kick | Reverse punch | Step forward and step back | Palgwe | 70–90% HRmax | 6 |
Roundhouse kick | Jab | 1 step and 2 step | Taegeuk | |||
Side kick | Hook punch | |||||
Axe kick | Upper cut | |||||
Back kick | Backfist | |||||
Turn kick | Hammer fist | |||||
Nara kick | ||||||
Circuit training | ||||||
60 | Interval running | Lunges | Squats | Pull-ups | 70–90% HRmax | 6 |
Chin-ups | Push-ups | Dips | ||||
Crunches | Leg lifts | |||||
10 | Static stretching | — | 6 |
Abbreviation: HRmax, maximum heart rate.
Dietary Intake
The participants’ lifestyle was highly controlled by researchers during the research period, as the study was conducted at a training camp with food intake and physical activity being supervised by trained instructors. Food logs were obtained during the training period. To lose weight, caloric restriction and exercise were used. Weight was measured every day before and after training sessions from each subject. The nutrient profile was 60% carbohydrates, 20% fats, and 20% protein. Before intervention of caloric restriction, nutritionists calculated the subjects’ mean caloric intake for the last 3 days and made a plan for the intake of calories to be progressively reduced by 400 kcal per day, totaling ∼2400 kcal over 6 days. Amount of meals were measured by balance (Hanna Instruments, Woonsocket, RI) and provided 3 times per day using a repeated treatment manner.
Intake of Octacosanol
Two capsules (20 mg each) of 100% refined octacosanol powder from sugar cane (Swanson, Fargo, ND) were consumed daily by the OCT group for 6 days, 1 capsule 30 minutes after morning and afternoon meals. The intake of octacosanol was followed in a double-blind manner with either a 20-mg capsule or a placebo twice a day. The daily concentration of octacosanol was determined from a previous study.15
Collection of Blood
Before and after the 6 days of this study, blood samples were collected from each subject. Caffeine and any drugs related to vascular function were prohibited 24 hours prior to collection of blood samples. A total of 15 mL of blood were collected between 9 and 10 AM by syringe (Bom Medrea Co, Ltd, Phnom Penh, Cambodia) after subjects had fasted for 12 hours. The blood samples were immediately centrifuged at 3000 rpm for 10 minutes at 4°C, and then plasma was collected and stored at −70°C until analysis.
Blood Lipid Profiles
To examine the levels of plasma lipids, HDL, LDL, total cholesterol, and TG were analyzed in duplicate using a chemistry analyzer (Hitachi 7600-210 and Hitachi 7180, Tokyo, Japan). Plasma samples were mixed with butylated hydroxytoluene and R1 reagent and reacted for 60 minutes at 45°C. After the reaction, the mixed samples were centrifuged at 2000 rpm for 10 minutes, and then supernatants were taken. The supernatants were read at 586 nm by a plate reader.
Redox Balance Measurements
Plasma levels of superoxide dismutase (SOD) were acquired by SOD Assay Kit-WST (Cayman Chemical, Ann Arbor, MI). Samples were mixed with WST working solution and enzyme working solution, and then the samples were incubated for 20 minutes at 37°C. The absorbances of the incubated samples were acquired at 450 nm by plate reader. The SOD activity was determined using a Cobas Mira chemistry analyzer (Roche, Basel, Switzerland). Malondialdehyde (MDA) was measured from BIOXTECHLPO-586 kit (Oxis Health Products, Inc, Portland, OR). The plasma samples were incubated with reagent diluent for 5 minutes at room temperature. The incubated samples were stimulated by Ran-Cell total antioxidant control (Randox, Crumlin, United Kingdom) and then analyzed at 340 nm by plate reader. Plasma levels of glutathione peroxidase (GPx) were acquired by GPx Assay Kit (Cayman Chemical). Samples were incubated for 20 minutes at 37°C. The absorbances of the incubated samples were acquired at 450 nm by plate reader. The GPx activity was determined using a Cobas Mira chemistry analyzer (Roche). The plasma samples were incubated with reagent diluent for 5 minutes at room temperature. The incubated samples were stimulated by Ran-Cell total antioxidant control (Randox) and then analyzed at 340 nm by plate reader.
Anthropometry and Body Composition
Body composition was assessed between 9 and 10 AM after a 12-hour fast before and after the 6-day training program using an 8-polar tactile-electrode impedance meter (InBody 720; Biospace, Seoul, South Korea), which simultaneously recorded body weight, fat mass, and fat-free mass. Height was measured with a stadiometer to the nearest 1 cm. Body mass index was calculated as weight in kilograms divided by height in meters squared. 16
Statistical Analysis
Data were analyzed using a 2 × 2 analysis of variance with repeated measures (group [OCT and CON] × time [before and after 6 d]). If a significant main effect or interaction was noted, a paired t test was used for within-group comparisons. Statistical analysis was performed using Statistical Package for the Social Science (SPSS) version 21.0 (IBM SPSS Analytics, Armonk, NY). The values were presented as mean and SE. A value of P < .05 was considered as statistically significant.
Results
Subject Characteristics
There were not any significant group × time interactions among groups in age, height, taekwondo experience, or percentage of body fat. Body weight and percentage of body fat following acute weight loss training was significantly lower (P < .05) than pretraining in both groups (Table 1).
Lipid Profiles
There were significant (P < .05) group × time differences in HDL, LDL, and TG levels between groups (Figure 2). The OCT group exhibited statistically significant increases in HDL (Δ10 [7] mg/dL) and decreases in LDL (Δ18 [5] mg/dL) and TG (Δ80 [7] mg/dL) between pretesting and posttesting, while the CON group showed a significant decrease in HDL levels (Δ22 [3] mg/dL) after posttesting.
Oxidative Stress
There were significant (P < .05) group × time differences between groups in all 3 oxidative stress markers after posttesting. The OCT group had a significant increase in SOD (Δ226 [121] U/gHb) after posttesting (Figure 3A), while the CON group experienced a significant decrease in GPx (Δ20 [13] U/gHb; Figure 3B) and a significant increase in MDA (Δ72 [0.04] nmol/mL; Figure 3C) after posttesting.
Discussion
After 6 days of a 5% weight loss through caloric restriction with high-intensity exercise training program, participants who consumed the supplement octacosanol experienced significant improvements in HDL, LDL, and TG levels when compared with the CON group. In addition, SOD, a marker of antioxidant capacity, was significantly increased in the OCT group after 6 days of training, while GPx, an antioxidant enzyme, was significantly reduced in the CON group. MDA, a marker of lipid peroxidation, was also significantly increased in the CON group, but not the OCT group. These results suggest that octacosanol can be used as a beneficial supplement for athletes who go through periods of caloric restriction with high-intensity exercise, as it was able to help protect against the detrimental changes in cholesterol levels and oxidative stress that occur from this kind of training.
The rapid weight loss through caloric restriction with high-intensity exercise training seen in taekwondo was shown to decrease levels of HDL and increase levels of LDL and TG, which may eventually increase the risks for both metabolic dysfunction and cardiovascular disease (CVD) in these athletes. However, the OCT group showed an increase in HDL and a reduction in LDL and TG, demonstrating the beneficial effects of octacosanol to reduce the negative changes in lipid levels that occur from this kind of training. HDL is believed to prevent and even remove cholesterol buildup in the arteries, and therefore, its increase would have beneficial effects on cardiovascular health and function,17,18 while increased levels of LDL and TG are known to be positively correlated with risks for metabolic and cardiovascular disorders.19,20 In fact, both increased HDL and reduced LDL levels have been shown to reduce mortality from CVD.21
These observed improvements in the OCT group may be due, in part, to the ability of octacosanol to inhibit the synthesis of cholesterol, as several studies have shown decreases in LDL, total cholesterol, and TG after octacosanol supplementation in both animals and humans.9–12,14 However, it seems more likely that octacosanol stimulates the conversion of lipids into energy, as an animal study reported that octacosanol intake resulted in greater serum free fatty acid levels, greater free fatty acid oxidation, and a decreased serum TG concentration when compared with a CON group.9 In addition, several studies, along with our own, have shown the ability of octacosanol to elicit an increase in serum HDL, a healthy cholesterol that increases the metabolism of LDL.14,22
Another detrimental effect from these periods of rapid weight loss through caloric restriction with high-intensity exercise is an increase in oxidative stress. Free radicals are continuously produced as part of cellular metabolic processes; however, these free radicals are typically neutralized by an endogenous antioxidant defense system consisting of the enzymes SOD and GPx, among others.23 During caloric restriction and high-intensity exercise, an imbalance between free radicals and antioxidants enzymes takes place, leading to oxidative stress.5 When this occurs, MDA is produced, a highly reactive chemical and a commonly used marker for oxidative stress, as it induces lipid peroxidation of the cell membrane, ultimately resulting in cell damage.24
In this study, MDA was significantly increased in the CON group, while there was no change in the OCT group, demonstrating the effects of this form of sports training to increase lipid peroxidation and the ability of octacosanol to reduce it. Along with its role as a scavenger for oxidative stress, octacosanol also improved antioxidant enzyme levels, as the OCT group had significantly greater SOD levels and the CON group had significantly lower GPx levels. Greater SOD and GPx levels, as seen in the OCT group, would be beneficial, as SOD eliminates harmful free oxygen radicals25 and GPx reduces the damaging effects of lipid peroxidation.26 These improvements are believed to be due to the antioxidant effects of octacosanol, as one study found strong antiradical properties of octacosanol (96.42% and 90.35% antiradical activity from the DPPH and ABTS radical scavenging assays, respectively),27 while another study demonstrated the ability of octacosanol to decrease oxidative stress markers in an animal model.28
This form of sports training may also lead to an increase in systemic inflammation, as inflammatory markers, such as C-reactive protein and interleukin-6, have been shown to be correlated with elevated lipid profiles and oxidative stress.29 An increase in these markers have also been linked to increased risks for CVD.30 Although not measured in this study, we believe this warrants further research, as octacosanol supplementation was shown to reduce both oxidative stress and LDL cholesterol levels in the OCT group. This suggests that it may also potentially reduce levels of inflammation that likely increase with this form of training as well.
Since taekwondo is a weight division sport, the participants of this sport repeatedly go through periods of rapid weight change with high-intensity exercise training in order to train at heavier body weights and then compete in lighter weight divisions. This results in poor lipid profiles and high levels of oxidative stress. Repeated exposure to this form of severe weight change with high-intensity training can result in impaired physiological function, which may eventually increase risks of metabolic dysfunction and CVD in these athletes. Therefore, it is important to find a nutritional treatment, such as octacosanol supplementation, in order to protect against the negative effects of this kind of sports training.
Practical Applications
These findings reveal that rapid weight loss paired with high-intensity exercise leads to poor lipid profiles and elevated levels of oxidative stress in taekwondo athletes. Chronic training in this manner may result in poor metabolic and cardiovascular health in these athletes and may interfere with sports performance. This study has shown that octacosanol supplementation reduced negative cholesterol and oxidative stress levels during taekwondo training, making it a potential therapeutic intervention in order to improve physiological function and prevent metabolic dysfunction in these athletes. Future research on octacosanol should examine larger sample sizes in various sports, as well as markers for inflammation.
Conclusion
As we have demonstrated in this study, octacosanol supplementation during rapid weight loss through caloric restriction with high-intensity exercise training improved lipid profiles and the balance between antioxidant enzymes and oxidative stress markers in taekwondo athletes. These findings suggest that octacosanol is a useful supplement for counteracting the potential negative effects of this form of training on health and performance in these kinds of athletes.
Acknowledgments
The authors are grateful to the participants. There was no funding source for this study. No conflicts of interest, financial or otherwise, are declared by the authors. Please contact author for data requests. Conception and design of the experiments: S.-H.L., J.-K.L., and S.-Y.P. Collection, assembly, analysis, and interpretation of data: S.-H.L., S.D.S., E.J.P., J.-K.L., and S.-Y.P. Drafting the article or revising it critically for important intellectual content: S.-H.L., S.D.S., E.J.P., J.-K.L., and S.-Y.P. This study was registered with clinicaltrials.gov (NTC03557476).
References
- 1.↑
Brownell KD, Steen SN, Wilmore JH. Weight regulation practices in athletes: analysis of metabolic and health effects. Med Sci Sports Exerc. 1987;19:546–556. PubMed ID: 3323766 doi:10.1249/00005768-198712000-00002
- 2.↑
Zambraski EJ, Tipton CM, Tcheng TK, Jordon HR, Vailas AC, Callahan AK. Iowa wrestling study: changes in the urinary profiles of wrestlers prior to and after competition. Med Sci Sports. 1975;7:217–220. PubMed ID: 1625
- 3.↑
Fogelholm GM, Koskinen R, Laakso J, Rankinen T, Ruokonen I. Gradual and rapid weight loss: effects on nutrition and performance in male athletes. Med Sci Sports Exerc. 1993;25:371–377. PubMed ID: 8455453 doi:10.1249/00005768-199303000-00012
- 4.↑
Steen SN, Brownell KD. Patterns of weight loss and regain in wrestlers: has the tradition changed? Med Sci Sports Exerc. 1990;22:762–768. PubMed ID: 2287253 doi:10.1249/00005768-199012000-00005
- 5.↑
Alessio HM. Exercise-induced oxidative stress. Med Sci Sports Exerc. 1993;25:218–224. PubMed ID: 8383786 doi:10.1249/00005768-199302000-00010
- 6.↑
Booth FW, Roberts CK. Linking performance and chronic disease risk: indices of physical performance are surrogates for health. Br J Sports Med. 2008;42:950–952. PubMed ID: 18838401 doi:10.1136/bjsm.2008.052589
- 7.↑
Mahjoub S, Masrour-Roudsari J. Role of oxidative stress in pathogenesis of metabolic syndrome. Caspian J Intern Med. 2012;3:386–396. PubMed ID: 26557292
- 8.↑
Taylor JC, Rapport L, Lockwood GB. Octacosanol in human health. Nutrition. 2003;19:192–195. PubMed ID: 12591561 doi:10.1016/S0899-9007(02)00869-9
- 9.↑
Kato S, Karino K, Hasegawa S, et al. Octacosanol affects lipid metabolism in rats fed on a high-fat diet. Br J Nutr. 1995;73:433–441. PubMed ID: 7766566 doi:10.1079/BJN19950045
- 10.
Shimura S, Hasegawa T, Takano S, Suzuki T. Studies on the effect of octacosanol on motor endurance in mice. Nutr Rep Int. 1987;36:1029–1038.
- 11.↑
Arruzazabala ML, Carbajal D, Mas R, Molina V, Valdes S, Laguna A. Cholesterol-lowering effects of policosanol in rabbits. Biol Res. 1994;27:205–208. PubMed ID: 8728832
- 12.↑
Castano G, Mas Ferreiro R, Fernandez L, Gámez R, Illnait J, Fernández C. A long-term study of policosanol in the treatment of intermittent claudication. Angiology. 2001;52:115–125. PubMed ID: 11228084 doi:10.1177/000331970105200205
- 13.↑
Hernandez F, Illnait J, Mas R, et al. Effect of policosanol on serum-lipids and lipoproteins in healthy-volunteers. Curr Ther Res Clin Exp. 1992;51:568–575.
- 14.↑
Mas R, Castano G, Illnait J, et al. Effects of policosanol in patients with type II hypercholesterolemia and additional coronary risk factors. Clin Pharmacol Ther. 1999;65:439–447. PubMed ID: 10223782 doi:10.1016/S0009-9236(99)70139-6
- 15.↑
Arruzazabala ML, Molina V, Mas R, et al. Antiplatelet effects of policosanol (20 and 40 mg/day) in healthy volunteers and dyslipidaemic patients. Clin Exp Pharmacol Physiol. 2002;29:891–897. PubMed ID: 12207568 doi:10.1046/j.1440-1681.2002.03746.x
- 16.↑
Wong A, Figueroa A, Son WM, Chernykh O, Park SY. The effects of stair climbing on arterial stiffness, blood pressure, and leg strength in postmenopausal women with stage 2 hypertension. Menopause. 2018;25(7):731–737. PubMed ID: 29438269 doi:10.1097/GME.0000000000001072
- 17.↑
Bezafibrate Infarction Prevention Study. Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease. Circulation. 2000;102:21–27. doi:10.1161/01.CIR.102.1.21.
- 18.↑
Pearson TA, Bulkley BH, Achuff SC, Kwiterovich PO, Gordis L. The association of low levels of HDL cholesterol and arteriographically defined coronary artery disease. Am J Epidemiol. 1979;109:285–295. PubMed ID: 222134 doi:10.1093/oxfordjournals.aje.a112682
- 19.↑
Castelli WP, Cooper GR, Doyle JT, et al. Distribution of triglyceride and total, LDL and HDL cholesterol in several populations: a cooperative lipoprotein phenotyping study. J Chronic Dis. 1977;30:147–169. PubMed ID: 191465 doi:10.1016/0021-9681(77)90082-0
- 20.↑
Manninen V, Tenkanen L, Koskinen P, et al. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment. Circulation. 1992;85:37–45. PubMed ID: 1728471 doi:10.1161/01.CIR.85.1.37
- 21.↑
Gotto AM, Gorry GA, Thompson JR, et al. Relationship between plasma lipid concentrations and coronary artery disease in 496 patients. Circulation. 1977;56:875–883. PubMed ID: 912850 doi:10.1161/01.CIR.56.5.875
- 22.↑
Gamez R, Maz R, Arruzazabala ML, Mendoza S, Castaño G. Effects of concurrent therapy with policosanol and omega-3 fatty acids on lipid profile and platelet aggregation in rabbits. Drugs R D. 2005;6:11–19. PubMed ID: 15806713 doi:10.2165/00126839-200506010-00002
- 23.↑
Urso ML, Clarkson PM. Oxidative stress, exercise, and antioxidant supplementation. Toxicology. 2003;189:41–54. PubMed ID: 12821281 doi:10.1016/S0300-483X(03)00151-3
- 24.↑
Jacob RA, Burri BJ. Oxidative damage and defense. Am J Clin Nutr. 1996;63:985S–990S. PubMed ID: 8644698 doi:10.1093/ajcn/63.6.985
- 25.↑
Nishikawa T, Edelstein D, Du XL, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature. 2000;404:787–790. PubMed ID: 10783895 doi:10.1038/35008121
- 26.↑
Thomas JP, Maiorino M, Ursini F, Girotti AW. Protective action of phospholipid hydroperoxide glutathione peroxidase against membrane-damaging lipid peroxidation. In situ reduction of phospholipid and cholesterol hydroperoxides. J Biol Chem. 1990;265:454–461. PubMed ID: 2294113
- 27.↑
Harrabi S, Ferchichi A, Bacheli A, Fellah H. Policosanol composition, antioxidant and anti-arthritic activities of milk thistle (Silybium marianum L.) oil at different seed maturity stages. Lipids Health Dis. 2018;17:82. PubMed ID: 29661192 doi:10.1186/s12944-018-0682-z
- 28.↑
Ohta Y, Ohashi K, Matsura T, Tokunaga K, Kitagawa A, Yamada K. Octacosanol attenuates disrupted hepatic reactive oxygen species metabolism associated with acute liver injury progression in rats intoxicated with carbon tetrachloride. J Clin Biochem Nutr. 2008;42:118–125. PubMed ID: 18385828 doi:10.3164/jcbn.2008017
- 29.↑
Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347:1557–1565. PubMed ID: 12432042 doi:10.1056/NEJMoa021993
- 30.↑
Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342:836–843. PubMed ID: 10733371 doi:10.1056/NEJM200003233421202